BD3095145
1-(2-Fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione , 95% , 830346-47-9
| Pack Size | Price | Stock | Quantity |
| 100mg | RMB32.00 | In Stock |
|
| 250mg | RMB47.20 | In Stock |
|
| 1g | RMB128.80 | In Stock |
|
| 5g | RMB414.40 | In Stock |
|
| 25g | RMB1377.60 | In Stock |
|
| 100g | RMB3854.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Density | 1.413±0.06 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Room Temperature |
| pka | 9.49±0.40(Predicted) |
| Appearance | White to off-white Solid |
| InChI | InChI=1S/C13H10F4N2O2/c1-7-5-11(20)18-12(21)19(7)6-8-9(13(15,16)17)3-2-4-10(8)14/h2-5H,6H2,1H3,(H,18,20,21) |
| InChIKey | IJRKKZXPXBTHER-UHFFFAOYSA-N |
| SMILES | C1(=O)N(CC2=C(C(F)(F)F)C=CC=C2F)C(C)=CC(=O)N1 |
Description and Uses
1-(2-Fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione is a pharmaceutical intermediate ingredient used in the preparation of Elagolix sodium, which is FDA-approved for the treatment of pain associated with moderate to severe pain associated with endometriosis.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |



![1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-5-iodo-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione](https://img.chemicalbook.com/CAS/GIF/1150560-54-5.gif)



![O-[2-(Vinyloxy)ethyl]hydroxylamine](https://img.chemicalbook.com/CAS2/GIF/391212-29-6.gif)